Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation.

Luo H, Rossi E, Saubamea B, Chasseigneaux S, Cochois V, Choublier N, Smirnova M, Glacial F, Perrière N, Bourdoulous S, Smadja DM, Menet MC, Couraud PO, Cisternino S, Declèves X.

Mol Pharm. 2019 Mar 4;16(3):1312-1326. doi: 10.1021/acs.molpharmaceut.8b01252. Epub 2019 Feb 5.

PMID:
30721081
2.

LC-MS/MS-based quantification of efflux transporter proteins at the BBB.

Gomez-Zepeda D, Taghi M, Smirnova M, Sergent P, Liu WQ, Chhuon C, Vidal M, Picard M, Thioulouse E, Broutin I, Guerrera IC, Scherrmann JM, Parmentier Y, Decleves X, Menet MC.

J Pharm Biomed Anal. 2019 Feb 5;164:496-508. doi: 10.1016/j.jpba.2018.11.013. Epub 2018 Nov 8.

PMID:
30453156
3.

Litigation and political transformation: the case of Russia.

Thornhill C, Smirnova M.

Theory Soc. 2018;47(5):559-593. doi: 10.1007/s11186-018-9327-5. Epub 2018 Sep 27.

4.

Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients.

Beaudreuil S, Schermann JM, Verstuyft C, Barrail-Tran A, Smirnova M, Durrbach A, Becquemont L.

Clin Transplant. 2018 Nov;32(11):e13405. doi: 10.1111/ctr.13405. Epub 2018 Oct 8. No abstract available.

PMID:
30298530
5.

High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier.

Taccola C, Cartot-Cotton S, Valente D, Barneoud P, Aubert C, Boutet V, Gallen F, Lochus M, Nicolic S, Dodacki A, Smirnova M, Cisternino S, Declèves X, Bourasset F.

Eur J Pharm Sci. 2018 May 30;117:68-79. doi: 10.1016/j.ejps.2018.02.005. Epub 2018 Feb 7.

PMID:
29427702
6.

Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor.

Jacquot G, Lécorché P, Malcor JD, Laurencin M, Smirnova M, Varini K, Malicet C, Gassiot F, Abouzid K, Faucon A, David M, Gaudin N, Masse M, Ferracci G, Dive V, Cisternino S, Khrestchatisky M.

Mol Pharm. 2016 Dec 5;13(12):4094-4105. Epub 2016 Oct 11.

PMID:
27656777
7.

Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging.

Auvity S, Chapy H, Goutal S, Caillé F, Hosten B, Smirnova M, Declèves X, Tournier N, Cisternino S.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2185-2195. doi: 10.1177/0271678X16662042. Epub 2016 Jan 1.

8.

Immune quiescence of the brain is set by astroglial connexin 43.

Boulay AC, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, Blugeon C, Mignon V, Smirnova M, Cavallo A, Ezan P, Avé P, Dingli F, Loew D, Vieira P, Chrétien F, Cohen-Salmon M.

J Neurosci. 2015 Mar 11;35(10):4427-39. doi: 10.1523/JNEUROSCI.2575-14.2015.

9.

Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.

Chapy H, Smirnova M, André P, Schlatter J, Chiadmi F, Couraud PO, Scherrmann JM, Declèves X, Cisternino S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu001. doi: 10.1093/ijnp/pyu001.

10.

Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Seleman M, Chapy H, Cisternino S, Courtin C, Smirnova M, Schlatter J, Chiadmi F, Scherrmann JM, Noble F, Marie-Claire C.

Psychopharmacology (Berl). 2014 Aug;231(16):3139-49. doi: 10.1007/s00213-014-3490-9. Epub 2014 Apr 5.

PMID:
24705903
11.

Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response.

Kuznetsova T, Tallo T, Brjalin V, Reshetnjak I, Salupere R, Priimagi L, Katargina O, Smirnova M, Jansons J, Tefanova V.

Hepat Mon. 2013 Dec 14;13(12):e14481. doi: 10.5812/hepatmon.14481. eCollection 2013.

12.

Monoclonal antibodies requiring coating buffer with low pH for efficient antigen capture in sandwich ELISA: the rarities or practically important phenomena?

Dmitriev AD, Tarakanova JN, Yakovleva DA, Dmitriev DA, Phartooshnaya OV, Kolyaskina GI, Massino YS, Borisova OV, Segal OL, Smirnova MB, Ulanova TI, Lavrov VF.

J Immunoassay Immunochem. 2013;34(4):414-37. doi: 10.1080/15321819.2013.764894.

PMID:
23859792
13.

Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice.

Alhaddad H, Cisternino S, Saubamea B, Schlatter J, Chiadmi F, Risède P, Smirnova M, Cochois-Guégan V, Tournier N, Baud FJ, Mégarbane B.

Toxicology. 2013 Mar 8;305:99-108. doi: 10.1016/j.tox.2013.01.013. Epub 2013 Jan 29.

PMID:
23376546
14.

Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Cisternino S, Chapy H, André P, Smirnova M, Debray M, Scherrmann JM.

AAPS J. 2013 Apr;15(2):299-307. doi: 10.1208/s12248-012-9434-6. Epub 2012 Dec 5.

15.

Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.

Alhaddad H, Cisternino S, Declèves X, Tournier N, Schlatter J, Chiadmi F, Risède P, Smirnova M, Besengez C, Scherrmann JM, Baud FJ, Mégarbane B.

Crit Care Med. 2012 Dec;40(12):3215-23. doi: 10.1097/CCM.0b013e318265680a.

PMID:
22975888
16.

Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2.

André P, Saubaméa B, Cochois-Guégan V, Marie-Claire C, Cattelotte J, Smirnova M, Schinkel AH, Scherrmann JM, Cisternino S.

J Cereb Blood Flow Metab. 2012 Nov;32(11):1989-2001. doi: 10.1038/jcbfm.2012.109. Epub 2012 Aug 1.

17.

ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.

Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S, Buyse M, Calon F, Chimini G, Chacun H, Scherrmann JM, Farinotti R, Bourasset F.

J Alzheimers Dis. 2012;30(1):155-66. doi: 10.3233/JAD-2012-112189.

PMID:
22391220
18.

The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.

Smirnova MV, Vostrov SN, Strukova EV, Dovzhenko SA, Kobrin MB, Portnoy YA, Zinner SH, Firsov AA.

J Antimicrob Chemother. 2009 Oct;64(4):815-20. doi: 10.1093/jac/dkp287. Epub 2009 Aug 11.

PMID:
19671586
19.

Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA.

Int J Antimicrob Agents. 2009 Mar;33(3):251-4. doi: 10.1016/j.ijantimicag.2008.09.006. Epub 2008 Dec 17.

PMID:
19095420
20.

Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.

Firsov AA, Smirnova MV, Strukova EN, Vostrov SN, Portnoy YA, Zinner SH.

Int J Antimicrob Agents. 2008 Dec;32(6):488-93. doi: 10.1016/j.ijantimicag.2008.06.031. Epub 2008 Sep 14.

PMID:
18790614

Supplemental Content

Loading ...
Support Center